What Is an Amniotic Membrane Allograft?

An amniotic membrane allograft is a biologic wound covering derived from the amnion, the innermost layer of the placenta. Used in a variety of clinical settings, this tissue-based product provides a scaffold for healing, offering structural support and bioactive signals that assist in tissue repair. While not a replacement for standard wound care, it plays a supportive role in managing chronic and complex wounds.

What the Amniotic Membrane Is and Why It Matters

The amniotic membrane is a natural, protective barrier that surrounds a fetus during pregnancy. It contains multiple layers rich in collagen, hyaluronic acid, and essential growth factors. After a live birth, placental tissue may be donated by consenting mothers. The donated material is then thoroughly screened, gently processed, and sterilized to ensure safety and preserve its functional properties.

When prepared for clinical use, the amniotic membrane is considered an allograft—human tissue transplanted from one individual to another. It is regulated under the FDA’s framework for human cells, tissues, and cellular and tissue-based products (HCT/Ps), and is commonly used in wound care as a protective biologic dressing.

Core Features of an Amniotic Membrane Allograft

What sets this type of allograft apart is its unique combination of handling characteristics, structural integrity, and biologic content. Many grafts on the market today feature:

  • Non-oriented, dual-layer design – can be applied facing either direction
  • Natural adherence – conforms to the wound bed without the need for sutures
  • Bioactive matrix – provides key proteins and growth factors that support healing
  • Stable storage – often room-temperature with shelf lives of up to five years
  • Size variety – available in multiple dimensions for different wound types and locations

These characteristics make the graft practical for a range of care environments, including clinics, hospitals, assisted living, and home health.

How It’s Used in Wound Care

Amniotic membrane allografts are applied to wounds that have proven slow to heal with conventional methods. Common applications include:

  • Diabetic foot ulcers
  • Venous leg ulcers
  • Pressure injuries
  • Dehisced surgical wounds
  • Traumatic injuries

These grafts are typically applied on a weekly basis, with the frequency and duration guided by a patient’s individual healing response and overall care plan. The allograft does not replace routine wound care steps like debridement, offloading, or infection control but serves as a biological dressing layered on top of those fundamentals.

What It Delivers

Amniotic membrane allografts provide more than coverage. They deliver a matrix of regenerative elements, including:

  • Collagen (Types I, III, IV, V, VII) – structural proteins essential for new tissue formation
  • Growth factors – such as VEGF, PDGF, EGF, and TGF-β, which support angiogenesis and cellular signaling
  • Anti-inflammatory properties – help modulate the local wound environment
  • Extracellular matrix proteins – like fibronectin and laminin, which guide cell migration

Together, these components help re-establish the conditions necessary for wound progression, particularly in stalled or non-healing wounds.

A Practical Biologic Option

For providers managing chronic wounds, an amniotic membrane allograft offers a tool that is both biologically active and clinically practical. It requires minimal preparation, integrates into existing treatment workflows, and is supported by a growing body of real-world and case-based evidence.

As part of a comprehensive wound care approach, amniotic allografts can help address healing barriers in a way that conventional dressings alone often cannot. Their structural and biochemical features make them a strong addition to the toolkit for complex wound management.

Request a Referral